In recent years, the cell and gene therapy market has grown at a rapid clip. The momentum is likely to continue. According to Vision Research Reports, the global cell and gene therapy market size could hit around $42.56 billion by 2030, growing at a CAGR of 39% from 2022 to 2030. The burgeoning demand in…
GenScript debuts single- and double-strand DNA service for cell and gene therapy development
The popularity of CRISPR-based non-viral gene insertion techniques is fueling interest in CRISPR/Cas genome-editing technology that uses the homology-directed repair (HDR) pathway to insert DNA sequences. To respond to that demand, biotech services firm GenScript has introduced GMP-compliant single-stranded DNA (ssDNA) and closed-end linear double-stranded DNA (dsDNA) services. The company’s GenExact ssDNA services support up to…
FDA signs off on first test detecting COVID-19 neutralizing antibodies
Today, the Food and Drug Administration issued an emergency use authorization (EUA) for the first serology test that identifies neutralizing antibodies resulting from a prior SARS-CoV-2 infection. The move could lead to an improved understanding of the role neutralizing antibodies play in COVID-19 infections. “The ability to detect neutralizing antibodies can help us gain additional…